Tadashi Terai

Title: The Innovations of Tadashi Terai

Introduction

Tadashi Terai is a notable inventor based in Kobe, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of aqueous liquid compositions and ophthalmic suspensions. With a total of 2 patents, his work has had a meaningful impact on medical treatments.

Latest Patents

One of his latest patents is an aqueous liquid pharmaceutical composition containing a benzopyran derivative. This invention aims to enhance the solubilization or suspension of a specific compound, pranlukast, in water. By incorporating surfactants, water-soluble cellulose derivatives, and water-soluble vinyl polymers, the composition achieves a higher concentration of pranlukast while maintaining desirable properties. Another significant patent involves an ophthalmic suspension containing difluprednate as an active ingredient. This formulation demonstrates superior anti-inflammatory and anti-allergic actions, making it beneficial for treating various eye disorders, including allergic conjunctivitis and uveitis.

Career Highlights

Throughout his career, Tadashi Terai has worked with prominent companies such as Senju Pharmaceutical Co., Ltd. and Mitsubishi Chemical Corporation. His experience in these organizations has allowed him to refine his expertise in pharmaceutical innovations.

Collaborations

Tadashi has collaborated with notable colleagues, including Takahiro Ogawa and Motoko Kimura. These partnerships have contributed to the advancement of his research and inventions.

Conclusion

Tadashi Terai's contributions to pharmaceutical innovations highlight his dedication to improving medical treatments. His patents reflect a commitment to enhancing the efficacy of pharmaceutical compositions, ultimately benefiting patients worldwide.